A kidney tumour is an abnormal growth or mass that develops in or around kidney tissue. Some kidney tumours are benign (non-cancerous), while others are malignant (cancerous). A mass detected on imaging does not automatically indicate cancer.
Kidney tumours may be discovered during imaging performed for unrelated medical conditions. Their evaluation depends on the size, appearance and location of the mass, kidney function, symptoms and other clinical factors.
Dr. Prakash Sankapal, a urologist in Navi Mumbai , provides urology consultations at NewEra Hospitals, Vashi, and JP Kidney Care, Ulwe. Further investigation and management are guided by individual clinical assessment.
What Is a Kidney Tumour?
A kidney tumour is a growth formed by cells within or around the kidney. Kidney masses can be solid or cystic, and their clinical significance varies.
A benign kidney tumour does not spread to distant organs in the way that cancer can. A malignant tumour contains cancerous cells and may invade nearby structures or spread to other parts of the body.
Not every kidney mass requires immediate surgery. Some lesions can be monitored, while others require further investigation or treatment.
Important: A kidney cyst, benign tumour and kidney cancer are different conditions. Imaging characteristics and clinical assessment help distinguish them.
What Are the Different Types of Kidney Tumours?
Kidney tumours include non-cancerous growths, primary kidney cancers and less common tumour types.
1. Renal Cell Carcinoma (RCC)
Renal cell carcinoma is the most common type of kidney cancer in adults. It begins in cells associated with the kidney’s filtering tubules.
RCC includes several subtypes, such as clear cell, papillary and chromophobe renal cell carcinoma.
2. Benign Renal Tumours
Some renal masses are non-cancerous. Examples include angiomyolipoma and oncocytoma.
Depending on their characteristics, selected benign tumours may require surveillance or treatment.
3. Renal Pelvis Urothelial Cancer
Urothelial carcinoma may develop in the lining of the renal pelvis, where urine collects before entering the ureter.
Its evaluation and management differ from renal cell carcinoma. Related urothelial conditions can also affect the bladder. Read about bladder stones and tumours .
4. Wilms Tumour
Wilms tumour is a kidney cancer that mainly affects children. Its investigation and treatment involve specialised paediatric oncology care.
5. Other Rare Kidney Tumours
Less common kidney tumours include certain mesenchymal tumours, sarcomas and other unusual neoplasms.
Accurate classification may require specialist radiological and pathological evaluation.
What Factors May Increase the Risk of Kidney Cancer?
Kidney cancer can develop without an identifiable risk factor. However, several factors are associated with increased risk.
- Smoking: Tobacco exposure is associated with increased kidney cancer risk.
- Excess body weight: Obesity is associated with renal cell carcinoma.
- High blood pressure: Hypertension is associated with increased risk.
- Family history: Some hereditary conditions increase susceptibility to kidney tumours.
- Age: Kidney cancer is more commonly diagnosed in older adults.
- Certain inherited syndromes: Conditions such as von Hippel–Lindau syndrome can increase kidney tumour risk.
Having a risk factor does not mean that a person will necessarily develop kidney cancer.
What Are the Symptoms of a Kidney Tumour?
Many small kidney tumours cause no noticeable symptoms and are discovered incidentally during imaging.
When symptoms occur, they may include:
- Blood in the urine (haematuria).
- Persistent pain in the side or back.
- A lump or swelling in the abdomen or flank.
- Unexplained weight loss.
- Reduced appetite or persistent tiredness.
- Unexplained fever in some cases.
- Anaemia or abnormal blood test results.
These symptoms can also occur with non-cancerous conditions, including kidney and ureteric stones or urinary infections.
Symptoms alone cannot confirm or exclude a kidney tumour.
When Should a Kidney Mass Be Medically Evaluated?
A newly detected solid kidney mass or complex renal cyst generally requires appropriate medical review.
Clinical assessment is also important for:
- Visible blood in the urine.
- Persistent unexplained flank or abdominal pain.
- An abnormal kidney finding on ultrasound or CT.
- Unexplained weight loss together with other concerning symptoms.
- A strong family history of hereditary renal cancer.
Urgent assessment: Heavy bleeding, inability to pass urine, severe pain or significant deterioration in general condition may require immediate medical attention.
How Are Kidney Tumours Diagnosed?
Evaluation usually includes medical history, examination, laboratory investigations and appropriate imaging.
1. Ultrasound
Ultrasound may identify a kidney mass and help distinguish some fluid-filled cysts from solid lesions. Additional imaging may be needed for characterisation.
2. Contrast-Enhanced CT
Multiphasic contrast-enhanced CT is commonly used to assess renal masses, including size, internal enhancement, location and possible extension.
3. MRI
MRI may be recommended when CT findings are uncertain or when more detailed evaluation of certain structures is required.
4. Blood and Urine Tests
Tests may assess kidney function, blood counts and other relevant medical findings. They cannot independently confirm kidney cancer.
5. Renal Mass Biopsy
A kidney mass biopsy involves obtaining a small tissue sample for laboratory examination.
Biopsy may be useful in selected circumstances, but it is not required for every kidney mass. The decision depends on imaging findings, treatment considerations and whether the result would influence management.
Further information: EAU guidance on renal tumour diagnostic evaluation .
What Are the Treatment Options for Kidney Tumours?
Kidney tumour management depends on whether the mass is benign or malignant, tumour characteristics, disease stage, kidney function, overall health and patient preferences.
1. Active Surveillance
Selected small renal masses may be monitored using scheduled imaging and clinical review.
This approach may be suitable when the expected risks of immediate treatment outweigh potential benefits, or in other selected clinical circumstances.
2. Partial Nephrectomy
Partial nephrectomy involves removing a kidney tumour while preserving the remaining kidney tissue when feasible.
It is commonly considered for selected localised renal tumours where adequate cancer control and kidney preservation are achievable.
3. Radical Nephrectomy
Radical nephrectomy involves removal of the affected kidney and, when clinically indicated, adjacent structures or tissue.
It may be considered when tumour features make kidney-sparing treatment unsuitable.
4. Thermal Ablation
Thermal ablation uses methods such as radiofrequency or cryoablation to treat selected small kidney masses.
It may be considered in particular patients after discussion of treatment limitations and recurrence risks.
5. Systemic Cancer Treatment
Some patients with advanced or metastatic renal cell carcinoma may require systemic therapies, including immunotherapy or targeted medicines.
Treatment selection depends on cancer subtype, disease extent and multidisciplinary oncology assessment.
Important: A kidney tumour does not automatically require removal of the entire kidney. The appropriate approach must be determined through specialist clinical assessment.
Kidney Tumour Management: General Comparison
Different approaches may be considered according to the individual diagnosis.
| Management Option | General Description |
|---|---|
| Active Surveillance | Scheduled monitoring of selected renal masses. |
| Partial Nephrectomy | Removal of the mass while preserving remaining kidney tissue. |
| Radical Nephrectomy | Removal of the affected kidney when clinically indicated. |
| Thermal Ablation | Destruction of selected lesions using specialised energy-based techniques. |
| Systemic Therapy | Medicines used in selected patients with advanced disease. |
For treatment guidance, see the European Association of Urology renal cell carcinoma guidelines .
What Are the Possible Risks of Kidney Tumour Surgery?
Partial and radical nephrectomy are surgical procedures with potential complications.
Risks may include:
- Bleeding or blood transfusion.
- Infection or wound complications.
- Injury to nearby structures.
- Blood clots or anaesthesia related complications.
- Reduced kidney function.
- Urine leakage after some partial nephrectomies.
- Need for additional procedures or treatment.
- Persistent or recurrent disease requiring follow-up.
Risks differ according to the operation, tumour characteristics, kidney function and overall health.
Is Follow-Up Required After Kidney Tumour Treatment?
Follow-up may be required after kidney tumour treatment to assess recovery, kidney function and the possibility of recurrence.
Depending on the diagnosis and treatment, follow-up may include:
- Review of symptoms and general health.
- Kidney function blood tests.
- Ultrasound, CT or MRI when indicated.
- Review of pathology and cancer stage.
- Monitoring for recurrence or progression.
- Discussion of lifestyle factors and other ongoing medical needs.
Follow-up schedules should be individualised according to disease characteristics, treatment and clinical risk.
Kidney Tumour Consultation in Vashi and Ulwe, Navi Mumbai
Dr. Prakash Sankapal provides urology consultations at NewEra Hospitals, Vashi, and JP Kidney Care, Ulwe.
Consultation for a suspected kidney mass may include reviewing medical history, imaging reports, kidney function and the need for further investigations.
NewEra Hospitals – Vashi
Sion–Panvel Highway,Sector 7, Vashi,
Navi Mumbai,
Maharashtra 400703.
Contact: +91 8007542142
JP Kidney Care – Ulwe
Plot No. 70,Moreshwar Heritage,
Sector 5, Ulwe,
Navi Mumbai,
Maharashtra 410206.
Contact: +91 8591009591
These are consultation locations. Availability of surgery or specialised oncology treatment at a particular facility should be confirmed separately.
See the clinic contact and consultation information page for updated details.
Frequently Asked Questions About Kidney Tumours
No. Some kidney tumours are benign, while others are malignant. Imaging and clinical assessment help determine further evaluation.
Early kidney cancer may cause no symptoms. Some patients experience blood in the urine, persistent flank pain or other changes. These symptoms can have different causes.
Kidney tumours are evaluated using imaging such as ultrasound, CT or MRI. Blood tests and selected biopsies may provide additional information.
No. Some renal masses can be monitored. Surgery or another intervention may be recommended according to tumour characteristics and individual risk.
Partial nephrectomy involves removing a kidney tumour while preserving the remaining kidney tissue when clinically feasible.
Radical nephrectomy is removal of the affected kidney, with adjacent tissue removed when indicated. It may be considered for selected tumours.
Many people live with one functioning kidney. The effect of kidney removal depends on existing kidney function, other medical conditions and long-term follow-up.
Yes. Malignant kidney tumours may spread beyond the kidney. The risk depends on cancer type, stage and other biological factors.
Follow-up is often recommended to monitor kidney function, recovery and recurrence risk. The schedule depends on the diagnosis and treatment received.
Dr. Prakash Sankapal provides urology consultations at NewEra Hospitals, Vashi, and JP Kidney Care, Ulwe. See the consultation locations and contact details .
Medical References
Additional educational information is available through the following medical resources.
Medical Disclaimer: Website content and visuals are for general informational, educational and representational purposes only, may not reflect individual patient conditions or outcomes, and do not replace personalised medical advice, diagnosis or clinical assessment.